EyePoint Pharmaceuticals, Inc.

NASDAQ:EYPT

11.63 (USD) • At close November 8, 2024
Bedrijfsnaam EyePoint Pharmaceuticals, Inc.
Symbool EYPT
Munteenheid USD
Prijs 11.63
Beurswaarde 792,637,661
Dividendpercentage 0%
52-weken bereik 5.86 - 30.99
Industrie Biotechnology
Sector Healthcare
CEO Dr. Jay S. Duker M.D.
Website https://eyepointpharma.com

An error occurred while fetching data.

Over EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intravitreal implant for intravitreal injection for

Vergelijkbare Aandelen

OraSure Technologies, Inc. logo

OraSure Technologies, Inc.

OSUR

4.29 USD

C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc.

CCCC

6.06 USD

Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc.

ANIK

17.26 USD

ALX Oncology Holdings Inc. logo

ALX Oncology Holdings Inc.

ALXO

1.45 USD

Absci Corporation logo

Absci Corporation

ABSI

4.07 USD

HilleVax, Inc. logo

HilleVax, Inc.

HLVX

1.91 USD

Heron Therapeutics, Inc. logo

Heron Therapeutics, Inc.

HRTX

1.75 USD

BioXcel Therapeutics, Inc. logo

BioXcel Therapeutics, Inc.

BTAI

0.68 USD

Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc.

FULC

3.49 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)